Retrospective Study
Copyright ©The Author(s) 2021.
World J Clin Oncol. Nov 24, 2021; 12(11): 1037-1046
Published online Nov 24, 2021. doi: 10.5306/wjco.v12.i11.1037
Figure 1
Figure 1 Progression-free survival (A) and overall survival (B) of the study population.

  • Citation: Buti S, Bersanelli M, Massari F, De Giorgi U, Caffo O, Aurilio G, Basso U, Carteni G, Caserta C, Galli L, Boccardo F, Procopio G, Facchini G, Fornarini G, Berruti A, Fea E, Naglieri E, Petrelli F, Iacovelli R, Porta C, Mosca A. First-line pazopanib in patients with advanced non-clear cell renal carcinoma: An Italian case series. World J Clin Oncol 2021; 12(11): 1037-1046
  • URL: https://www.wjgnet.com/2218-4333/full/v12/i11/1037.htm
  • DOI: https://dx.doi.org/10.5306/wjco.v12.i11.1037